Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?
Journal of Hand and Microsurgery · 2025-05 · 17 (3) · 100223
DOI: 10.1016/j.jham.2025.100223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hand and Microsurgery, 2025-05. Verfasst von Omar El Sewify und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Laval University, 1050 Av. de la Médecine, Quebec City, Canada. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Nonsurgical therapeutic approaches for thumb carpometacarpal (CMC) osteoarthritis (OA) often offer only inconsistent symptom relief and fail to restore hand function. Intra-articular platelet-rich plasma (PRP) injections have recently emerged as a promising alternative, with encouraging outcomes in knees and hips. This systematic review and meta-analysis aims to highlight the safety and efficacy of PRP injections in thumb CMC OA. A systematic review was completed using Medline, Embase, and Cochrane. Primary outcomes focused on patients with basal thumb osteoarthritis treated with intra-articular PRP injections. Patient characteristics, product administration, functional outcomes and complications were analyzed as means of central tendency. A meta-analysis was performed focusing on pain relief and improvement in hand function. Seven articles were included, comprising 115 patients with an average age of 62.6 years, predominantly female (67.0 %). Patients received an average of 1.4 PRP injections per joint, with an average follow-up of 14.1 months. Control groups were administered corticosteroids, normal saline, and hyaluronic acid. All PRP-treated patients resumed their prior activities of daily living with a satisfaction rate at 73.7 % (n = 76). Statistically significant pain reduction (n = 98) and improvement in pinch strength were reported, while no statistically significant improvement in grip strength was observed (n = 39). No adverse events occurred, with only one complication (a palmar wrist ganglion) reported. Intra-articular PRP injections in thumb CMC OA yields favorable outcomes for pain relief and hand function without major complications. However, procedural and data heterogeneity affect reliability. Further randomized controlled trials comparing PRP and cortisone injections are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Laval University, 1050 Av. de la Médecine, Quebec City, Canada.
- Division of Plastic, Reconstructive & Aesthetic Surgery, University of Toronto, 149 College Street, Toronto, Canada.
- Faculty of Medicine and Health Sciences, McGill University, 3605 de la Montagne Street, Montreal, Canada.
- Hand and Reconstructive Microsurgery, National University Hospital (NUH), 5 Lower Kent Ridge Rd, Singapore.
- Plastic and Reconstructive Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, 1000 Saint-Denis Street, Montreal, Canada.
Zitieren
APA
El Sewify, O., Datta, S., Legler, J., Sylvain, M., Cheah, A., & Efanov, J. I. (2025). Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?. Journal of Hand and Microsurgery, 17(3), 100223. https://doi.org/10.1016/j.jham.2025.100223
Vancouver
El Sewify O, Datta S, Legler J, Sylvain M, Cheah A, Efanov JI. Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?. Journal of Hand and Microsurgery. 2025;17(3):100223. doi:10.1016/j.jham.2025.100223
BibTeX
@article{ElSewify2025,
author = {El Sewify, Omar and Datta, Shaishav and Legler, Jack and Sylvain, Marion and Cheah, Andre and Efanov, Johnny I},
title = {Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?},
journal = {Journal of Hand and Microsurgery},
year = {2025},
volume = {17},
number = {3},
pages = {100223},
doi = {10.1016/j.jham.2025.100223}
}
EUVIMED